Page: 26 of 30 22 23 24 25 26 27 28 29 30

Sarah Marshall - Epidemiologist, University of California, Irvine Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Although hormone supplements have been implicated in increased rates of breast cancer, they appear to mitigate the mortality risk of breast cancer...

Dr Luca Gianni - Director of Medical Oncology, National Cancer Institute, Milan Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Among patients with HER2-positive, locally advanced breast cancer, neoadjuvant treatment with Herceptin increased three-year, event-free survival ...

Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 After one to four years of tamoxifen, switching to anastrozole improves disease-free survival by about 31 percent, but patients pay a price in qua...

Dr. William Wood, Chairman of the Department of Surgery, Emory University School of Medicine Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Pre-emptive surgey to remove breasts and ovaries to prevent breast cancer in high risk BRCA1 and BRCA2 gene carrying patients; many factors to take...

Dr Slyvia Nagl, University College London Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 From the 2008 ICT-BIO EU conference. Complex Events and Emergence in Cancer Systems. Sylvia Nagl, Ph.D. , Cancer Institute, The Paul O’Gorman Buil...

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Discusses his role in the AZA trial, the findings and higher and lower risk MDS patient responses. Interviewed at ASH 2009. Lewis Silverman is an ...

Professor Norbert Graf, Director of Oncology and Haematology Clinic, University of Saarland Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Lecture from the European Union ICT BIO 2008 Conference (Oct. 23-24, 2008) on Clinical Requirements Regarding In Silico Oncology

Dr Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, London Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 A reduction in breast density of at least 10 percent may predict who benefits from the breast cancer preventive effects of tamoxifen. Researchers s...

Prof Umberto Veronesi - Director of the European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Prof Umberto Veronesi, Director of the European Institute of Oncology, Milan, and Founding editor of ecancer, discusses the role of open access an...

Dr Alberto D’Onofrio - Group Leader in Theoretical Biology and Medicine, Department of Experimental Oncology, European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Dr Alberto D’Onofrio, Group Leader in Theoretical Biology and Medicine, Department of Experimental Oncology, European Institute of Oncology, Milan...

Dr Alan Coates - School of Public Health, University of Sydney Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmeno...

Prof Roberto Orecchia - Director of Radiation Department, European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Prof Roberto Orecchia, Director of Radiation Department, European Institute of Oncology, Milan discusses Hadron therapy, available facilities in E...

Dr Florence Didier - Co-Director of the Psycho-oncology Unit, European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Dr Florence Didier, Co-Director of the Psycho-oncology Unit, European Institute of Oncology, Milan, talks about her department’s work to help pati...

Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of Oncology, Milan, discusses her research into bacteria as agents to...

Dr Carlo Cipolla - Director of the Cardioncology Division, European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Dr Carlo Cipolla, head of the International Cardioncology Society, talks to ecancer about the new field, his work at the IEO, and collaborations.

Dr Fabrizio Luca - Division of Abdominopelvic Surgery, European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Dr Fabrizio Luca, Senior Vice-Director of the Division of Abdominopelvic Surgery, European Institute of Oncology, Milan, discusses the advantages ...

www.ecancer.tv Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Animation depicting gene mutation and causes. Courtesy of CancerQuest at Emory University.

Dr Charles Mullighan - Department of Pathology, St Jude Children’s Research Hospital Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Charles Mullighan, M.B.B.S. (Hons), M.Sc., M.D., assistant member, department of pathology, St. Jude Children’s Research Hospital presents at the ...

www.ecancer.tv Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Short animation depicting programmed cell death known as 'apoptosis'.Courtesy of CancerQuest at Emory University.

Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women’s Hospital, Harvard Medical School, USA Channel: www.ecancer.tv Length: 0 Date: September 30, 2009 Daniel W. Cramer, M.D., Sc.D., professor of obstetrics and gynecology, Brigham and Women’s Hospital, Harvard Medical School, presents at AACR 2009...

Page: 26 of 30 22 23 24 25 26 27 28 29 30